Goodwin Procter advised FountainVest Partners on the deal.FountainVest Partners announced the acquisition of China-based Beijing Zhendong Langdi Pharmaceutical Co., Ltd. for approximately US$900 million. FountainVest is now…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
